Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "OctPM pathway control state"

From Bioblast
Line 5: Line 5:
'''MitoPathway control state:''' FN
'''MitoPathway control state:''' FN


'''SUIT protocol:''' [[SUIT_FNSGp(PGM)01]] - SUIT RP1, [[SUIT_FNSGp(PGM)02]] - SUIT RP1
'''SUIT protocol:''' [[1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-]] - SUIT RP1, [[SUIT_FNSGp(PGM)02]] - SUIT RP1


This substrate combination supports N-linked flux which is typically higher than FAO capacity (F/FN<0 in the OXPHOS state). In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare [[malate anaplerotic pathway control state]], M alone), and pyruvate is added to compare FAO as the background state with FN as the reference state.
This substrate combination supports N-linked flux which is typically higher than FAO capacity (F/FN<0 in the OXPHOS state). In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare [[malate anaplerotic pathway control state]], M alone), and pyruvate is added to compare FAO as the background state with FN as the reference state.
Line 19: Line 19:


== OctPM(E) ==
== OctPM(E) ==
:::# [[SUIT_FNSGp(PGM)01]]_'''4Oct''': 1PM 2D&Dc (&DcNADH) 3U '''<u>4Oct</u>''' 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd
:::# [[1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-]]_'''4Oct''': 1PM 2D&Dc (&DcNADH) 3U '''<u>4Oct</u>''' 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd


----
----

Revision as of 12:24, 22 January 2018


high-resolution terminology - matching measurements at high-resolution


OctPM pathway control state

Description

OctPM: Octanoylcarnitine & Pyruvate & Malate.

MitoPathway control state: FN

SUIT protocol: 1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp- - SUIT RP1, SUIT_FNSGp(PGM)02 - SUIT RP1

This substrate combination supports N-linked flux which is typically higher than FAO capacity (F/FN<0 in the OXPHOS state). In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare malate anaplerotic pathway control state, M alone), and pyruvate is added to compare FAO as the background state with FN as the reference state.

Abbreviation: OctPM

Reference: MiPNet21.06 SUIT reference protocol


MitoPedia concepts: SUIT state 

OctPM(L)

OctPM(P)

  1. SUIT_FNSGp(PGM)02_4P: 1D 2Oct 3Mtit&Mc (&McNADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd

OctPM(E)

  1. 1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-_4Oct: 1PM 2D&Dc (&DcNADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd

SUIT RP1


SUIT RP2